Literature DB >> 5791479

Suppression of Raynaud's phenomenon by methyldopa.

D P Varadi, A M Lawrence.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5791479

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  6 in total

Review 1.  Pathogenesis and treatment of Raynaud's phenomenon.

Authors:  J D Coffman
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 2.  Influence of vasospasm on visual function.

Authors:  P Gasser; J Flammer
Journal:  Doc Ophthalmol       Date:  1987-05       Impact factor: 2.379

3.  Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication.

Authors:  M Lepäntalo
Journal:  Br J Clin Pharmacol       Date:  1984-07       Impact factor: 4.335

4.  Urinary incontinence due to interaction of phenoxybenzamine and alpha-methyldopa.

Authors:  P G Fernandez; S Sahni; B A Galway; S Granter; J McDonald
Journal:  Can Med Assoc J       Date:  1981-01-15       Impact factor: 8.262

5.  Prostaglandin E1 infusions for vascular insufficiency in progressive systemic sclerosis.

Authors:  M F Martin; P M Dowd; E F Ring; E D Cooke; P A Dieppe; J D Kirby
Journal:  Ann Rheum Dis       Date:  1981-08       Impact factor: 19.103

6.  Skin capillary blood flow in scleroderma.

Authors:  E C LeRoy; J A Downey; P J Cannon
Journal:  J Clin Invest       Date:  1971-04       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.